Medtronic Derivative, Fair Value, Amount Offset Against Collateral, Net increased by 29.4% to $264.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 58.0%, from $629.00M to $264.00M. Over 5 years (FY 2020 to FY 2025), Derivative, Fair Value, Amount Offset Against Collateral, Net shows an upward trend with a 16.0% CAGR.
other_derivative_fair_value_amount_offset_against_collat_1dfba4| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$148.00M | $4.00M | $118.00M | $131.00M | $312.00M | $315.00M | $329.00M | $33.00M | $121.00M | $110.00M | $468.00M | $411.00M | $492.00M | $477.00M | $428.00M | $629.00M | $42.00M | $6.00M | $204.00M | $264.00M |
| QoQ Change | — | +102.7% | >999% | +11.0% | +138.2% | +1.0% | +4.4% | -90.0% | +266.7% | -9.1% | +325.5% | -12.2% | +19.7% | -3.0% | -10.3% | +47.0% | -93.3% | -85.7% | >999% | +29.4% |
| YoY Change | — | — | — | — | +310.8% | >999% | +178.8% | -74.8% | -61.2% | -65.1% | +42.2% | >999% | +306.6% | +333.6% | -8.5% | +53.0% | -91.5% | -98.7% | -52.3% | -58.0% |